Cancer and autoimmunity: Harnessing longitudinal cohorts to probe the link.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Baillière's Best Practice & Research : Clinical Rheumatology

• Publication date

  2016-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.berh.2016.03.001PMID 27421216PMCID PMC4947510
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Erratum to: Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis

  2016cited by this paper
• Cancer and scleroderma: a paraneoplastic disease with implications for malignancy screening

  2015cited by this paper
• Malignancies in systemic lupus erythematosus: a 2015 update

  2015cited by this paper
• Drug-associated dermatomyositis following ipilimumab therapy: a novel immune-mediated adverse event associated with cytotoxic T-lymphocyte antigen 4 blockade.

  2015cited by this paper
• A6.44 Only BAFF mRNA, not BAFF protein level in blood, is associated with SLE activity over one year

  2015cited by this paper
• Primary CNS lymphoproliferative disease, mycophenolate and calcineurin inhibitor usage

  2015cited by this paper
• Examination of Autoantibody Status and Clinical Features Associated With Cancer Risk and Cancer‐Associated Scleroderma

  2015cited by this paper
• Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL) and Sclerostin Are Related to Joint Destruction in Early Rheumatoid Arthritis Unrelated to Polymorphisms of the Genes

  2015cited by this paper
• Antibodies to early EBV, CMV, and HHV6 antigens in systemic lupus erythematosus patients

  2015cited by this paper
• Case of respiratory discomfort due to myositis after administration of nivolumab

  2015cited by this paper
• Incidence of Cancer in ANCA-Associated Vasculitis: A Meta-Analysis of Observational Studies

  2015cited by this paper
• Polymyositis/dermatomyositis and Malignancy Risk: A Metaanalysis Study

  2015cited by this paper
• Review: Cancer‐Induced Autoimmunity in the Rheumatic Diseases

  2015cited by this paper
• Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis

  2015cited by this paper
• Arthritis and tenosynovitis associated with the anti-PD1 antibody pembrolizumab in metastatic melanoma.

  2015cited by this paper
• Breast cancer in systemic sclerosis: results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature.

  2014cited by this paper
• Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis

  2014cited by this paper
• Drug‐Associated Polymyalgia Rheumatica/Giant Cell Arteritis Occurring in Two Patients After Treatment With Ipilimumab, an Antagonist of CTLA‐4

  2014cited by this paper
• Association of the Autoimmune Disease Scleroderma with an Immunologic Response to Cancer

  2014cited by this paper
• Therapeutic targeting of the BAFF/APRIL axis in systemic lupus erythematosus

  2014cited by this paper
• Systemic lupus erythematosus is associated with increased incidence of hematologic malignancies: a meta-analysis of prospective cohort studies.

  2014cited by this paper
• Systemic lupus erythematosus and malignancies: a review article.

  2014cited by this paper
• Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and systemic lupus erythematosus

  2014cited by this paper
• Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma

  2014cited by this paper
• Epstein-Barr Virus in Systemic Autoimmune Diseases

  2013cited by this paper
• Primary Sjögren's syndrome and malignancy risk: a systematic review and meta-analysis

  2013cited by this paper
• Screening for Lung Cancer With Low-Dose Computed Tomography: A Systematic Review to Update the U.S. Preventive Services Task Force Recommendation

  2013cited by this paper
• Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1γ.

  2013cited by this paper
• Cancer risk in systemic lupus: an updated international multi-centre cohort study.

  2013cited by this paper
• Cancer incidence in systemic sclerosis: meta-analysis of population-based cohort studies.

  2013cited by this paper
• A Clinical Prediction Rule for Lymphoma Development in Primary Sjögren’s Syndrome

  2012cited by this paper
• Rheumatology and oncology: an updated review of rheumatic manifestations of malignancy and anti-neoplastictherapy.

  2012cited by this paper
• Lymphoma risk in systemic lupus: effects of disease activity versus treatment

  2012cited by this paper
• Cancer Risk of Anti-TNF-α at Recommended Doses in Adult Rheumatoid Arthritis: A Meta-Analysis with Intention to Treat and per Protocol Analyses

  2012cited by this paper
• The influence of anti-TNF therapy upon incidence of keratinocyte skin cancer in patients with rheumatoid arthritis: longitudinal results from the British Society for Rheumatology Biologics Register

  2012cited by this paper
• Radiologic manifestations of immune-related adverse events in patients with metastatic melanoma undergoing anti-CTLA-4 antibody therapy.

  2011cited by this paper
• Expression of APRIL in Diffuse Large B Cell Lymphomas from Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis

  2011cited by this paper
• Scar carcinoma of the lung: a historical perspective.

  2011cited by this paper
• Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort

  2011cited by this paper
• Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren's syndrome

  2011cited by this paper
• Malignancies in Italian Patients with Systemic Sclerosis Positive for Anti-RNA Polymerase III Antibodies

  2011cited by this paper
• High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: a long-term followup study in a Danish cohort.

  2011cited by this paper
• Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I/III antibodies.

  2010cited by this paper
• Effects of the new immunosuppressive agents on the occurrence of malignancies after renal transplantation.

  2010cited by this paper
• Incidence and prevention of bladder toxicity from cyclophosphamide in the treatment of rheumatic diseases: a data-driven review.

  2010cited by this paper
• Validity of Self-Reported Comorbidities in Systemic Sclerosis

  2009cited by this paper
• Incidence of and risk factors for skin cancer after heart transplant.

  2009cited by this paper
• Significant risk factors for occurrence of cancer after renal transplantation: a single center cohort study of 1265 cases.

  2009cited by this paper
• Biologic Treatment of Rheumatoid Arthritis and the Risk of Malignancy: Analyses From a Large US Observational Study

  2009cited by this paper
• Rheumatoid arthritis, treatment with corticosteroids and risk of malignant lymphomas: results from a case–control study

  2009cited by this paper
• Hematologic Manifestations and Predictors of Lymphoma Development in Primary Sjögren Syndrome: Clinical and Pathophysiologic Aspects

  2009cited by this paper
• Cancer-related inflammation

  2008cited by this paper
• Lung cancer risk following detection of pulmonary scarring by chest radiography in the prostate, lung, colorectal, and ovarian cancer screening trial.

  2008cited by this paper
• Paraneoplastic scleroderma secondary to hairy cell leukaemia successfully treated with cladribine.

  2008cited by this paper
• Malignancies in Wegener's granulomatosis: incidence and relation to cyclophosphamide therapy in a cohort of 293 patients.

  2008cited by this paper
• Biologic treatment of rheumatoid arthritis and the risk of malignancy: analyses from a large US observational study.

  2007cited by this paper
• Persistent chronic inflammation contributes to the development of cancer in patients with rheumatoid arthritis from a defined population of northwestern Spain.

  2007cited by this paper
• Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis.

  2006cited by this paper
• Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer.

  2006cited by this paper
• Non-Hodgkin’s lymphoma in systemic lupus erythematosus

  2005cited by this paper
• Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy

  2005cited by this paper
• Prospective Registry‐Based Observational Cohort Study of the Long‐Term Risk of Malignancies in Renal Transplant Patients Treated with Mycophenolate Mofetil

  2005cited by this paper
• Gemcitabine-associated scleroderma-like changes of the lower extremities.

  2004cited by this paper
• Digital necrosis related to carboplatin and gemcitabine therapy in systemic sclerosis.

  2003cited by this paper
• NF-κB in cancer: from innocent bystander to major culprit

  2002cited by this paper
• NF-kappaB in cancer: from innocent bystander to major culprit.

  2002cited by this paper
• Inflammation and cancer: back to Virchow?

  2001cited by this paper
• Incidence of Malignant Disease in Biopsy-Proven Inflammatory Myopathy: A Population-Based Cohort Study

  2001cited by this paper
• Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study.

  2001cited by this paper
• Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy.

  2000cited by this paper
• Systemic Sclerosis Revealing T-Cell Lymphoma

  1999cited by this paper
• Secondary Raynaud's phenomenon and other late vascular complications following chemotherapy for testicular cancer.

  1995cited by this paper
• Immunosuppression-associated lymphoproliferative disorders in rheumatic patients.

  1995cited by this paper
• The overall and temporal association of cancer with polymyositis and dermatomyositis.

  1994cited by this paper
• Cancer in systemic sclerosis.

  1993cited by this paper
• Exaggerated radiation-induced fibrosis in patients with systemic sclerosis.

  1991cited by this paper
• Post‐irradiation morphoea

  1989cited by this paper
• Incidence of lung cancer in systemic sclerosis.

  1985cited by this paper
• Bleomycin-induced scleroderma.

  1980cited by this paper
• Cutaneous toxicity of bleomycin therapy.

  1973cited by this paper

• Head and neck cancer risk in patients with rheumatoid arthritis compared with matched controls: a nationwide cohort study

  2026cites this paper
• Sarcoma in patients with systemic lupus erythematosus. A systematic review.

  2025cites this paper
• Leukemias in the Context of Rheumatoid Arthritis: Shared Pathways and Clinical Perspectives

  2025cites this paper
• Autoimmune diseases and diffuse large B-cell lymphoma: A Mendelian randomization study

  2025cites this paper
• Complete remission of unresectable advanced esophageal squamous cell carcinoma following nivolumab immunotherapy after chemoradiotherapy: a case report

  2025cites this paper
• Risk relationship between six autoimmune diseases and malignancies: An umbrella review.

  2025cites this paper
• Insights into autoimmunity and cancer

  2025cites this paper
• Urological cancer risk in patients with rheumatoid arthritis compared to matched controls: A nationwide cohort study.

  2025cites this paper
• Diagnostic challenges of neurosarcoidosis in non-endemic areas

  2024cites this paper
• A case of treatment-refractory paraneoplastic polymyalgia rheumatica that improved after tumor resection

  2024cites this paper
• Immune-Mediated Inflammatory Diseases and Cancer - a dangerous liaison

  2024cites this paper
• Exploring the Link between Head and Neck Cancer and Elevated Risk of Rheumatoid Arthritis: A National Population-Based Cohort Study

  2024cites this paper
• F-18-FDG PET-CT in investigating possible malignancy associated with rheumatic disease: beware of excessive radiation

  2024influential citation
• Malignancies in systemic rheumatic diseases: A mini review

  2023cites this paper
• Red and white lesion of the tongue in a patient with cutaneous findings.

  2022cites this paper
• Asociación entre cáncer papilar de tiroides, vitíligo, morfea y síndrome de Sjögren, ¿una nueva variante del síndrome autoinmune múltiple?

  2022cites this paper
• Immunomodulatory effects of Blaps rynchopetera extract

  2022cites this paper
• Association Between Autoimmune Rheumatic Diseases and Head and Neck Cancer: Systematic Review and Meta-Analysis.

  2022cites this paper
• Autoimmune Responses in Oncology: Causes and Significance

  2021influential citation
• Antibody therapeutics and immunoregulation in cancer and autoimmune disease.

  2020cites this paper
• The relationships between cancer and autoimmune rheumatic diseases.

  2020cites this paper
• Autoimmune diseases and hematological malignancies: Exploring the underlying mechanisms from epidemiological evidence.

  2020cites this paper
• Cancer and Scleroderma.

  2020cites this paper
• Cancer Risk in a Large Inception Systemic Lupus Erythematosus Cohort: Effects of Demographic Characteristics, Smoking, and Medications

  2020cites this paper
• Dually Efficacious Medicine Against Fibrosis and Cancer

  2019cites this paper
• Risk of Cancers in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Results from the Korea National Health Insurance Claims Database 2010–2018

  2019cites this paper
• THU0675 ASSOCIATION OF GLUCOSE HOMEOSTASIS MEASURES AND METABOLIC SYNDROME WITH KNEE CARTILAGE DEFECTS AND CARTILAGE VOLUME IN YOUNG ADULTS

  2019cites this paper
• Malignancy risk in Korean male patients with ankylosing spondylitis

  2019cites this paper
• Oncologic evaluation in rheumatologic differential diagnosis

  2019cites this paper
• PTEN Hamartoma Tumor Syndrome and Immune Dysregulation123

  2018cites this paper
• Exploring the interplay between autoimmunity and cancer to find the target therapeutic hotspots

  2018cites this paper
• Dual Targeting Autoimmunity and Cancer: From Biology to Medicine

  2018cites this paper
• Dermatomyositis and Immune-Mediated Necrotizing Myopathies: A Window on Autoimmunity and Cancer

  2017cites this paper
• Effects of Transitioning to Medicare Part D on Access to Drugs for Medical Conditions among Dual Enrollees with Cancer.

  2017cites this paper
• Mechanistic and clinical insights at the scleroderma-cancer interface

  2017cites this paper
• International Journal of Molecular Sciences the Double Role of P53 in Cancer and Autoimmunity and Its Potential as Therapeutic Target

  year unknowncites this paper